富士製薬工業(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4554/E00975 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/06/02 | 日証協 | 191,191株 | +32.34% | 54,282株 | -42.89% | 191,545株 | +7.34% | 83,201株 | +305.86% |
| 2017/05/26 | 日証協 | 144,474株 | +32.64% | 95,048株 | +127.83% | 178,445株 | +20.05% | 20,500株 | -77.87% |
| 2017/05/19 | 日証協 | 108,918株 | +11.49% | 41,718株 | +42.43% | 148,645株 | +69.79% | 92,619株 | +1374.12% |
| 2017/05/12 | 日証協 | 97,691株 | -2.67% | 29,291株 | +76.45% | 87,544株 | -9.6% | 6,283株 | +1156.6% |
| 2017/05/02 | 日証協 | 100,374株 | +0.7% | 16,600株 | -33.8% | 96,844株 | +0.62% | 500株 | -85.71% |
| 2017/04/28 | 日証協 | 99,674株 | +2.36% | 25,074株 | +63.09% | 96,244株 | +2.67% | 3,500株 | +16.67% |
| 2017/04/21 | 日証協 | 97,374株 | +2.4% | 15,374株 | +32.74% | 93,744株 | +0.74% | 3,000株 | -38.78% |
| 2017/04/14 | 日証協 | 95,091株 | -5.66% | 11,582株 | -26.21% | 93,054株 | -5.58% | 4,900株 | -0.18% |
| 2017/04/07 | 日証協 | 100,796株 | +0.72% | 15,696株 | -71.02% | 98,554株 | +8.75% | 4,909株 | -45.62% |
| 2017/03/31 | 日証協 | 100,074株 | +1.42% | 54,165株 | +288.34% | 90,625株 | -39.44% | 9,028株 | +145.13% |
| 2017/03/24 | 日証協 | 98,674株 | -0.92% | 13,948株 | +77.14% | 149,653株 | +2.12% | 3,683株 | +75.38% |
| 2017/03/17 | 日証協 | 99,591株 | -0.78% | 7,874株 | -28.25% | 146,553株 | +0.41% | 2,100株 | -34.38% |
| 2017/03/10 | 日証協 | 100,374株 | -0.3% | 10,974株 | -28.03% | 145,953株 | +1.88% | 3,200株 | -44.84% |
| 2017/03/03 | 日証協 | 100,674株 | +12.39% | 15,248株 | +164.03% | 143,253株 | +6.63% | 5,801株 | -21.61% |
| 2017/02/24 | 日証協 | 89,575株 | +0.45% | 5,775株 | -46.28% | 134,352株 | +0.3% | 7,400株 | +57.38% |
| 2017/02/17 | 日証協 | 89,175株 | +1.23% | 10,750株 | +60.66% | 133,952株 | +0.75% | 4,702株 | +80.85% |
| 2017/02/10 | 日証協 | 88,091株 | -2.22% | 6,691株 | +22.37% | 132,950株 | -2.28% | 2,600株 | -18.39% |
| 2017/02/03 | 日証協 | 90,091株 | +0.46% | 5,468株 | +58.31% | 136,050株 | +2.25% | 3,186株 | +45.75% |
| 2017/01/27 | 日証協 | 89,677株 | -5.38% | 3,454株 | +2.28% | 133,050株 | -3.83% | 2,186株 | +68.15% |
※株式分割は考慮していませんのでご注意ください。
Page Top